Identification of novel regulators associated with early-phase osteoblast differentiation

被引：76

作者：

de Jong, DS

Vaes, BLT

Dechering, KJ

Feijen, A

Hendriks, JMA

Wehrens, R

Mummery, CL

van Zoelen, EJJ

Olijve, W

Steegenga, WT

机构：

[1] Univ Nijmegen, Dept Cell Biol, Fac FNWI, NL-6525 ED Nijmegen, Netherlands

[2] Univ Nijmegen, Dept Appl Biol, NL-6525 ED Nijmegen, Netherlands

[3] NV Organon, Target Discovery Unit, Oss, Netherlands

[4] Netherlands Inst Dev Biol, Hubrecht Lab, NL-3584 CT Utrecht, Netherlands

[5] Univ Nijmegen, Dept Analyt Chem, Nijmegen, Netherlands

来源：

JOURNAL OF BONE AND MINERAL RESEARCH | 2004年 / 19卷 / 06期

关键词：

microarrays; osteoblast; bone morphogenetic protein 2; differentiation; transcription factors;

D O I：

10.1359/JBMR.040216

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Key regulatory components of the BMP-induced osteoblast differentiation cascade remain to be established. Microarray and subsequent expression analyses in mice identified two transcription factors, Hey1 and Tcf7, with in vitro and in vivo expression characteristics very similar to Cbfa1. Transfection studies suggest that Tcf7 modulates BMP2-induced osteoblast differentiation. This study contributes to a better definition of the onset of BMP-induced osteoblast differentiation.

引用

页码：947 / 958

页数：12

共 60 条

[31] Cbfa1 contributes to the osteoblast-specific expression of type I collagen genes
Kern, B
Shen, JH
Starbuck, M
Karsenty, G
[J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (10) : 7101 - 7107
[32] Transforming growth factor-β-stimulated clone-22 is a member of a family of leucine zipper proteins that can homo- and heterodimerize and has transcriptional repressor activity
Kester, HA
Blanchetot, C
den Hertog, J
van der Saag, PT
van der Burg, B
[J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (39) : 27439 - 27447
[33] Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts
Komori, T
Yagi, H
Nomura, S
Yamaguchi, A
Sasaki, K
Deguchi, K
Shimizu, Y
Bronson, RT
Gao, YH
Inada, M
Sato, M
Okamoto, R
Kitamura, Y
Yoshiki, S
Kishimoto, T
[J]. CELL, 1997, 89 (05) : 755 - 764
[34] Identification and functional characterization of distinct critically important bone morphogenetic protein-specific response elements in the Id1 promoter
Korchynskyi, O
ten Dijke, P
[J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (07) : 4883 - 4891
[35] Runx2 is a common target of transforming growth factor β1 and bone morphogenetic protein 2, and cooperation between Runx2 and Smad5 induces osteoblast-specific gene expression in the pluripotent mesenchymal precursor cell line C2C12
Lee, KS
Kim, HJ
Li, QL
Chi, XZ
Ueta, C
Komori, T
Wozney, JM
Kim, EG
Choi, JY
Ryoo, HM
Bae, SC
[J]. MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (23) : 8783 - 8792
[36] A human Mad protein acting as a BMP-regulated transcriptional activator
Liu, F
Hata, A
Baker, JC
Doody, J
Carcamo, J
Harland, RM
Massague, J
[J]. NATURE, 1996, 381 (6583) : 620 - 623
[37] Helix-loop-helix-type transcription factor (HES-1) is expressed in osteoblastic cells, suppressed by 1,25(OH)(2) vitamin D-3, and modulates 1,25(OH)(2) vitamin D-3 enhancement of osteopontin gene expression
Matsue, M
Kageyama, R
Denhardt, DT
Noda, M
[J]. BONE, 1997, 20 (04) : 329 - 334
[38] The mammalian basic helix loop helix protein HES-1 binds to and modulates the transactivating function of the Runt-related factor Cbfa1
McLarren, KW
Lo, R
Grbavec, D
Thirunavukkarasu, K
Karsenty, G
Stifani, S
[J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (01) : 530 - 538
[39] Identification of Smad7, a TGF beta-inducible antagonist of TGF-beta signalling
Nakao, A
Afrakhte, M
Moren, A
Nakayama, T
Christian, JL
Heuchel, R
Itoh, S
Kawabata, N
Heldin, NE
Heldin, CH
tenDijke, P
[J]. NATURE, 1997, 389 (6651) : 631 - 635
[40] Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5

← 1 2 3 4 5 6 →